Paul Frewer

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Pasi A. Jänne, James Chih‐Hsin Yang, Dong‐Wan Kim et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab

Marc E. Rothenberg, Amy D. Klion, Florence Roufosse et al. · New England Journal of Medicine · 2008 · 569 citations · Full text

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

Lecia V. Sequist, Ji‐Youn Han, Myung‐Ju Ahn et al. · The Lancet Oncology · 2020 · 406 citations · Full text

Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

Wolfgang H. Oertel, Erik Ch. Wolters, Cristina Sampaio et al. · Movement Disorders · 2005 · 208 citations

Parkinson Disease, Pharmacology, Clinical Trials +13

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

Eric Van Cutsem, Yu Jeong Bang, Wasat Mansoor et al. · Annals of Oncology · 2017 · 183 citations · Full text

Gene Amplification, Gastrointestinal Oncology, Medicine +6